Literature DB >> 17615276

Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury.

Jakob Vinten-Johansen1, Zhi-Qing Zhao, Rong Jiang, Amanda J Zatta, Geoffrey P Dobson.   

Abstract

Reperfusion is the definitive treatment to salvage ischemic myocardium from infarction. A primary determinant of infarct size is the duration of ischemia. In myocardium that has not been irreversibly injured by ischemia, reperfusion induces additional injury in the area at risk. The heart has potent innate cardioprotective mechanisms against ischemia-reperfusion that reduce infarct size and other presentations of postischemic injury. Ischemic preconditioning (IPC) applied before the prolonged ischemia exerts the most potent protection observed among known strategies. It has been assumed that IPC exerts protection during ischemia. However, recent data suggest that cardioprotection is also exerted during reperfusion. Postconditioning (PoC), defined as brief intermittent cycles of ischemia alternating with reperfusion applied after the ischemic event, has been shown to reduce infarct size, in some cases equivalent to that observed with IPC. Although there are similarities in mechanisms of cardioprotection by these two interventions, there are key differences that go beyond simply exerting these mechanisms before or after ischemia. A significant limitation of IPC has been the inability to apply this maneuver clinically except in situations where the ischemic event can be predicted. On the other hand, PoC is applied at the point of service in the hospital (cath-lab for percutaneous coronary intervention, coronary artery bypass grafting, and other cardiac surgery) where and when reperfusion is initiated. Initial clinical studies are in agreement with the success and extent to which PoC reduces infarct size and myocardial injury, even in the presence of multiple comorbidities.

Entities:  

Mesh:

Year:  2007        PMID: 17615276     DOI: 10.1152/japplphysiol.00642.2007

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  25 in total

1.  Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.

Authors:  Ming Cai; Zachary M Huttinger; Heng He; Weizhi Zhang; Feng Li; Lauren A Goodman; Debra G Wheeler; Lawrence J Druhan; Jay L Zweier; Karen M Dwyer; Guanglong He; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  J Mol Cell Cardiol       Date:  2011-09-12       Impact factor: 5.000

Review 2.  Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.

Authors:  Aslan T Turer; Joseph A Hill
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

3.  Expression of inducible nitric oxide synthase in muscle flaps treated with ischemic postconditioning.

Authors:  Mei Yang; Michael F Angel; Yi Pang; John J Angel; Zhe Wang; Michael W Neumeister; Nathan Wetter; Feng Zhang
Journal:  Hand (N Y)       Date:  2012-09

4.  Ischemic preconditioning in the younger and aged heart.

Authors:  Pasquale Abete; Gianluca Testa; Francesco Cacciatore; David Della-Morte; Gianluigi Galizia; Assunta Langellotto; Franco Rengo
Journal:  Aging Dis       Date:  2011-02-06       Impact factor: 6.745

Review 5.  High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.

Authors:  C Roger White; Samantha Giordano; G M Anantharamaiah
Journal:  Chem Phys Lipids       Date:  2016-05-02       Impact factor: 3.329

6.  Emulsified isoflurane postconditioning produces cardioprotection against myocardial ischemia-reperfusion injury in rats.

Authors:  Zhao-Yang Hu; Geoffrey W Abbott; Ya-Dong Fang; Yue-Sheng Huang; Jin Liu
Journal:  J Physiol Sci       Date:  2013-04-27       Impact factor: 2.781

7.  Long-term protection and mechanism of pacing-induced postconditioning in the heart.

Authors:  Fawzi A Babiker; Ilka Lorenzen-Schmidt; Eric Mokelke; Ward Y Vanagt; Tammo Delhaas; Johannes Waltenberger; Jack P Cleutjens; Frits W Prinzen
Journal:  Basic Res Cardiol       Date:  2010-03-25       Impact factor: 17.165

Review 8.  Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning.

Authors:  Satoshi Matsuzaki; Pamela A Szweda; Luke I Szweda; Kenneth M Humphries
Journal:  Adv Drug Deliv Rev       Date:  2009-08-26       Impact factor: 15.470

9.  Effect of HEMADO on Level of CK-MB and LDH Enzymes after Ischemia/Reperfusion Injury in Isolated Rat Heart.

Authors:  Mohammad Amani; Sajad Jeddi; Nasser Ahmadiasl; Nasibe Usefzade; Jalal Zaman
Journal:  Bioimpacts       Date:  2012-11-13

Review 10.  Protective ischaemia in patients: preconditioning and postconditioning.

Authors:  Asger Granfeldt; David J Lefer; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.